Bottom line
What is EGORX's expense ratio?
EGORX's expense ratio is 0.65%, or about $65 a year on every $10,000 invested. That is cheaper than 67% of large blend funds we track (median 0.83%). It has no front-end sales load.
Updated Nov 24, 2025
EGORX fee table
| Net expense ratio | 0.65% |
|---|---|
| Gross expense ratio | 0.78% |
| Management fee | 0.7% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.08% |
| Fee waiver / reimbursement | -0.13% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Nov 24, 2025
What EGORX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EGORX | $66 | $236 | $420 | $954 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.65% expense ratio costs roughly $37,100 in lost growth, versus about $46,700 for the median large blend fund (0.83%).